Maximise Your Product Revenue through International Protection of Your Patent Portfolio
Pharma IQ's 5th Annual Pharmaceutical & Biotech Patent Litigation Strategies Conference 2010 will help you to learn the most effective strategies for protecting essential patent revenue streams and that accurate, informed decisions are made to protect and litigate patents effectively.
For example, on site you will be able to hear valuable insights from fellow high calibre professionals:
• Discover patent litigation from a practical corporate perspective and familiarise yourself with the challenges of different courts and the solutions for successful litigation with Mr John Meidahl, Divisional Director, Lundbeck
• Learn about important recent cases in Europe and how to deal with their implications in your future patent filing strategies with Mr André Bourgouin, VP Corporate Intellectual Property, Ipsen Pharma
• Examine inequitable conduct defence in US patent litigation to help you understand the intricacies of inequitable conduct, disclosure requirements and prior art in the US with Dr Seth Fidel Lead IP Counsel, Merrimack Pharmaceuticals, Inc.
• Assess the prospect of a supra national court and the effects it may have on patent litigation in the Biotechnology and Pharmaceutical sectors with Mr Justice Floyd, Judge of the Patents Court, UK
Event Only price: 1998 GBP
Pharma IQ's 5th Annual Pharmaceutical & Biotech Patent Litigation Strategies Conference 2010 will help you to learn the most effective strategies for protecting essential patent revenue streams and that accurate, informed decisions are made to protect and litigate patents effectively.
For example, on site you will be able to hear valuable insights from fellow high calibre professionals:
• Discover patent litigation from a practical corporate perspective and familiarise yourself with the challenges of different courts and the solutions for successful litigation with Mr John Meidahl, Divisional Director, Lundbeck
• Learn about important recent cases in Europe and how to deal with their implications in your future patent filing strategies with Mr André Bourgouin, VP Corporate Intellectual Property, Ipsen Pharma
• Examine inequitable conduct defence in US patent litigation to help you understand the intricacies of inequitable conduct, disclosure requirements and prior art in the US with Dr Seth Fidel Lead IP Counsel, Merrimack Pharmaceuticals, Inc.
• Assess the prospect of a supra national court and the effects it may have on patent litigation in the Biotechnology and Pharmaceutical sectors with Mr Justice Floyd, Judge of the Patents Court, UK
Event Only price: 1998 GBP
